[MACC plus thymostimulin (TP-1 Serono) therapy of small cell bronchogenic carcinoma. Clinico-immunologic evaluation of the results of a randomized trial]

G Ital Chemioter. Jan-Aug 1984;31(1-2):185-9.
[Article in Italian]
No abstract available

Publication types

  • Clinical Trial
  • English Abstract

MeSH terms

  • Aged
  • Antineoplastic Combined Chemotherapy Protocols*
  • Carcinoma, Bronchogenic / drug therapy*
  • Carcinoma, Small Cell / drug therapy*
  • Clinical Trials as Topic
  • Cyclophosphamide / administration & dosage
  • Doxorubicin / administration & dosage
  • Female
  • Humans
  • Lomustine / administration & dosage
  • Lung Neoplasms / drug therapy*
  • Male
  • Methotrexate / administration & dosage
  • Middle Aged
  • Random Allocation
  • Thymus Extracts / administration & dosage

Substances

  • Thymus Extracts
  • thymostimulin
  • Lomustine
  • Doxorubicin
  • Cyclophosphamide
  • Methotrexate

Supplementary concepts

  • MACC combination